WO2003021230A2 - Systeme de mesure electrophysiologique de grande capacite - Google Patents

Systeme de mesure electrophysiologique de grande capacite Download PDF

Info

Publication number
WO2003021230A2
WO2003021230A2 PCT/US2002/028398 US0228398W WO03021230A2 WO 2003021230 A2 WO2003021230 A2 WO 2003021230A2 US 0228398 W US0228398 W US 0228398W WO 03021230 A2 WO03021230 A2 WO 03021230A2
Authority
WO
WIPO (PCT)
Prior art keywords
fluid
measurement apparatus
substrate
electrodes
electrophysiological measurement
Prior art date
Application number
PCT/US2002/028398
Other languages
English (en)
Other versions
WO2003021230A3 (fr
Inventor
Kirk S. Schroeder
Bradley D. Neagle
Original Assignee
Essen Instruments, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2002/016122 external-priority patent/WO2002095357A2/fr
Application filed by Essen Instruments, Inc. filed Critical Essen Instruments, Inc.
Priority to EP02780275A priority Critical patent/EP1434850A2/fr
Priority to AU2002343338A priority patent/AU2002343338A1/en
Publication of WO2003021230A2 publication Critical patent/WO2003021230A2/fr
Publication of WO2003021230A3 publication Critical patent/WO2003021230A3/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/48707—Physical analysis of biological material of liquid biological material by electrical means
    • G01N33/48728—Investigating individual cells, e.g. by patch clamp, voltage clamp
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N2035/00178—Special arrangements of analysers
    • G01N2035/00237—Handling microquantities of analyte, e.g. microvalves, capillary networks
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/10—Devices for transferring samples or any liquids to, in, or from, the analysis apparatus, e.g. suction devices, injection devices
    • G01N2035/1027—General features of the devices
    • G01N2035/1034—Transferring microquantities of liquid

Definitions

  • the invention relates to electrophysiology. More particularly, the invention relates to systems for performing electrophysiological measurements, typically in parallel, and typically without direct human intervention, especially to understand the properties and/or interactions of specific membrane components, such as ligand-gated ion channels and/or transporters.
  • Ion channels are protein- based pores found in the cell membrane that are responsible for maintaining the electrochemical gradients between the extracellular environment and the cell cytoplasm. These channels quite often are selectively permeable to a particular type of ion, e.g., calcium, chloride, potassium, or sodium.
  • the channels generally comprise two parts: (1) the pore itself, and (2) a switch mechanism that regulates the conductance of the pore.
  • the switch mechanism may be controlled by transmembrane voltage changes, covalent modification, mechanical stimulation, and/or chemical ligands (e.g., through the activation or deactivation of an associated membrane receptor), among others.
  • Ion channels are passive elements in that, once opened, ions flow in the direction of existing electrochemical gradients.
  • Ion transporters are similar to ion channels in that they are involved in the transport of ions across cell membranes; however, they differ from ion channels in that they require energy for their function and in that they tend to pump actively against established electrochemical gradients.
  • Ion channels are prevalent in the body and are necessary for many physiological functions, including the beating of the heart, the contraction of voluntary muscles, and the signaling of neurons. They also are found in the linings of blood vessels, allowing for physiological regulation of blood pressure, and in the pancreas, allowing for the control of insulin release. As such, the study of ion channels is a very diverse and prolific area encompassing basic academic research as well as biotechnical and pharmaceutical research.
  • ion channels may be performed on cell lines that endogenously express the ion channel of interest ("native channels") as well as on recombinant expression systems such as the Xenopus oocyte or mammalian cell lines (e.g., CHO, HEK, etc.) that have been transiently or stably transfected to express the ion channel by well-known techniques [2, 3]. Electrophysiology also is performed on isolated cell membranes or vesicles as well as on synthetic membranes where solubilized channels are reconstituted into a manufactured membrane [4].
  • FIG. 1 shows a typical patch clamp measurement geometry.
  • a glass capillary 2 is first heated and pulled to a fine tip.
  • the capillary is then filled with a saline buffer solution 4 and fitted with a Ag/AgCl electrode 6.
  • the function of the Ag/AgCl electrode is to provide an electrical connection to a wire via the reversible exchange of chloride ions in the pipette solution.
  • the user finds a biological cell or cell membrane 8 containing ion channels 10 of interest and gently touches the cell membrane with the pipette.
  • the measurement circuit is completed via the external ionic solution 12 and a second Ag/AgCl bath electrode 14.
  • a high-impedance operational amplifier 16 senses the current flowing in the circuit, which is subsequently recorded and analyzed with a data recording system 18.
  • a key to the successful function of the technique is the ability to form a high electrical resistance ( ⁇ 1 G ⁇ ) seal between the glass pipette and the cell membrane 20, so that the current recorded by the amplifier is dominated by ions 22 flowing through the cell membrane and not by ions flowing around the glass pipette directly into the bath solution.
  • the whole-cell voltage clamp is one of the more common configurations.
  • the portion of membrane at the end of the pipette 24 is permeabilized so as effectively to place the pipette electrode inside the cell. This, in turn, allows for an external voltage command 26 to be placed between the intracellular pipette electrode and the extracellular bath electrode, thereby providing control of the cell's transmembrane voltage potential.
  • the term "whole cell” is derived from the fact that, with this configuration, the instrument measures the majority of the currents in the entire cell membrane.
  • Permeabilization often is achieved by using voltage pulses of sufficient strength and duration that the membrane inside the pipette physically breaks down. This approach is well known in the field and is commonly referred to as "zapping" [8]. Permeabilization also may be achieved by using certain antibiotics, such as Nystatin and Amphotericin B [9]. These antibiotics work by forming chemical pores in the cell membrane that are permeable to monovalent ions, such as chloride. Since chloride is the current-carrying ion for the commonly used Ag/AgCl electrode, these antibiotics can produce a low resistance electrical access to the interior of the cell.
  • U.S. Patent No. 6,063,260 to Olesen describes a system intended to improve the throughput and decrease the fluid volume required of standard patch clamp technology.
  • the improvement relies on using a standard HPLC autosampler apparatus integrated into a standard patch clamp arrangement to more easily inject multiple fluids samples into the measurement system.
  • the invention claims to increase throughput by making multiple sequential fluid additions to the same biological membrane faster and easier.
  • the Olesen invention is deficient in several respects. First, it does not allow for a plurality of different biological samples to be measured simultaneously. Second, it does not eliminate the labor-intensive aspects of micromanipulation involved in standard patch clamp electrophysiology.
  • the invention may address these and/or other shortcomings by providing instrumentation for automated, high-throughput studies of ion channels.
  • ligand-gated channels are activated or deactivated by chemical or ligand binding. These channels may be gated by specific chemical messengers, such as the release of intracellular calcium, adenosine 3 ',5' - monophosphate (cyclic AMP or cAMP), or acetylcholine (ACh), among others.
  • chemical activation of an ion channel is extracellular in its initiation, and, in other cases, the chemical activation is intracellular. This implies that it is important that the compound not only can be released on the time scale of tens of milliseconds, but in some cases that the compound can be introduced within the membrane of a living cell.
  • the invention may address these and/or other shortcomings by providing channel assays for automated, high-throughput studies of voltage and/or ligand-gated ion channels.
  • the invention provides systems, including apparatus and methods, for performing electrophysiological measurements on membranous samples, including living cells, isolated cell fragments (such as organelles), and/or artificial membranes (such as vesicles).
  • the apparatus may include a high-throughput electrophysiological measurement system, and components thereof.
  • This measurement system may include, among others, (1) a fluidics head for transferring samples and/or other compounds to a perforated measurement substrate, (2) a pressure-regulated plenum system for positioning samples on the substrate and subsequently forming a high- resistance electrical seal, (3) an activation system (such as a computer-controlled pulsed UN illumination module) for activating caged compounds, (4) an electronics head for applying and/or measuring voltage and/or current, and/or (5) a computer- controlled analysis system for collecting and/or analyzing data.
  • the methods may include methods for performing high-throughput electrophysiological measurements on transporters and voltage or ligand-gated ion channels, sequentially and/or simultaneously.
  • Figure 1 is a schematic view of a prior-art patch clamp electrophysiology configuration, showing measurement geometry.
  • Figure 2 is a schematic view of the formation of an electrical seal between a single cell and a single hole in a substrate, in accordance with aspects of the invention.
  • Figure 3 is a schematic view of aperture geometry, showing two configurations for seal formation, in accordance with aspects of the invention.
  • Figure 4 is a graph showing command voltage protocol and measured electrical leak resistance between a transfected CHO cell and a SiO 2 -coated Kapton- film aperture.
  • Figure 5 is a graph showing whole cell physiological currents measured on CHO cells transfected with the voltage-gated potassium channel Kv3.2, for a voltage sweep from -100 mV to +60 mV, and for a voltage step protocol from -70 mN to various step voltages.
  • Figure 6 is a partially schematic view of an exemplary system platform layout for conducting high-throughput electrophysiological measurements, in accordance with aspects of the invention.
  • Figure 7 is a picture of the system platform layout of Figure 6, showing additional features of the layout.
  • Figure 8 is an alternative schematic view of the system platform layout of Figure 6, showing additional features of the layout.
  • Figure 9 is a picture of a system cabinet and bottle layout for conducting high- throughput electrophysiological measurements, in accordance with aspects of the invention.
  • FIG. 10 is an exploded perspective view of an exemplary membrane carrier, membrane substrate, and plenum, in accordance with aspects of the invention.
  • Figure 11 is a schematic view of an exemplary plenum fluidics system, in accordance with aspects of the invention.
  • Figure 12 is a schematic view of an exemplary plenum vacuum regulation system, in accordance with aspects of the invention.
  • Figure 13 is a set of views of an exemplary sample-handling fluidics head, in accordance with aspects of the invention.
  • Figure 14 is an exploded partially perspective, partially schematic view of an exemplary electronics head, in accordance with aspects of the invention.
  • Figure 15 is a schematic view of portions of the system of Figure 14, showing the use of two separate banks of electrode pins.
  • Figure 16 is a schematic view of an exemplary activation system, showing how light energy may be directed via optical fibers to a plurality of biological samples, in accordance with aspects of the invention.
  • Figure 17 is a screen shot from an exemplary graphical user interface showing
  • Figure 18 is a screen shot from an exemplary graphical user interface showing 48 time traces from a "seal test" electrical measurement, in accordance with aspects of the invention.
  • Figure 19 is a screen shot from an exemplary graphical user interface showing 48 time traces from a electrophysiological recording of sodium channels in CHO cells, in accordance with aspects of the invention.
  • Figure 20 is a screen shot from an exemplary graphical user interface regarding data file naming conventions, directory handling, and display of experiment summaries, in accordance with aspects of the invention.
  • Figure 21 is a screen shot from an exemplary graphical user interface regarding the setup and timing of a resistance "seal test," along with plate usage definitions, in accordance with aspects of the invention.
  • Figure 22 is a screen shot from an exemplary graphical user interface regarding the setup and timing of the addition of a perforation agent to the experimental protocol, along with experiment "type" definitions, in accordance with aspects of the invention.
  • Figure 23 is a screen shot from an exemplary graphical user interface regarding the setup and timing of the command voltage waveform protocols used in high-throughput electrophysiological recordings, in accordance with aspects of the invention.
  • Figure 24 is a screen shot from an exemplary graphical user interface regarding the setup and timing of the fluidics head compound additions and manual voltage offset corrections used in high-throughput electrophysiological recordings, in accordance with aspects of the invention.
  • Figure 25 is a screen shot from an exemplary graphical user interface regarding the display of compiled success rates and plate "hits" for a high-throughput electrophysiological data set, in accordance with aspects of the invention.
  • Figure 26 is a screen shot from an exemplary graphical user interface showing four electrophysiological traces of sodium currents corresponding to one non-active compound from a high-throughput electrophysiological data set, in accordance with aspects of the invention.
  • Figure 27 is a screen shot from an exemplary graphical user interface regarding the setup and definition processing "metrics" used in data reduction analysis of high-throughput electrophysiological recordings, in accordance with aspects of the invention.
  • Figure 28 are time traces of electrophysiological data showing the effects of resistance leak correction on a high-throughput electrophysiological data trace, in accordance with aspects of the invention.
  • the invention provides systems, including apparatus and methods, for performing electrophysiological measurements on membranous samples, including living cells, isolated cell fragments (such as organelles), and/or artificial membranes (such as vesicles).
  • the apparatus may include a high-throughput electrophysiological measurement system, and components thereof.
  • This measurement system may include, among others, (1) a fluidics head for transferring samples and/or other compounds to a perforated measurement substrate, (2) a pressure-regulated fluidics system for positioning samples on the substrate and subsequently forming a high- resistance electrical seal, (3) an activation system (such as a computer-controlled pulsed UV illumination module) for activating caged compounds, (4) an electronics head for applying and/or measuring voltage and/or current, and/or (5) a computer- controlled analysis system for collecting and/or analyzing data.
  • the methods may include methods for performing high-throughput electrophysiological measurements, for example, using activatable or caged compounds to study ligand-gated ion channels and transporters, sequentially and/or simultaneously.
  • the systems provided by the invention may allow electrophysiological measurements to be performed more quickly and/or easily than with standard patch clamp techniques, such that thousands of single-cell electrophysiological recordings may be acquired in a single day.
  • the systems provided by the invention preferably utilize a single, small (e.g., several micron diameter) aperture in an at least substantially planar substrate to provide the sealing function.
  • the systems may allow cells or biological membranes to be maneuvered to the aperture by fluid flow.
  • these systems may not only make the measurement easier, by reducing or eliminating the need for a direct human operator, a microscope, and/or a micromanipulating arm, but they also may provide a format suitable for achieving multiple electrical seals in parallel, thereby increasing the measurement throughput of the device.
  • the systems provided by the invention may be capable of forming high- resistance electrical seals, on the order of tens of M ⁇ to 1 G ⁇ , for example, through appropriate selection and processing of the substrate material, aperture geometry, and attention to the way in which the biological membrane interacts with the substrate.
  • Preferred substrates include thin plastic films, in which small apertures have been photomachined using a laser. These substrates optionally may be vacuum deposited with thin layers of glass to aid in the formation of the high-resistance seal. Additional, suitable substrates may include silicon wafers, in which small apertures have been produced using standard photolithographic/wet etching techniques. In any case, individual cells may be positioned onto isolated apertures using a suitable positioning method, such as differential pressure.
  • FIG. 2 depicts a measurement geometry with for a single measurement chamber, in accordance with aspects of the invention.
  • a single hole 30 ( ⁇ 1 to 3 ⁇ m diameter) is formed in the bottom of a chamber 32.
  • An electrical circuit is implemented through the use of a Ag/AgCl sensing electrode 34 in contact with an ionic saline solution 36.
  • a second isolated fluid chamber 38 allows fluid access to a bottom side of hole 30 in conjunction with a bath electrode 40, thereby completing the measurement circuit.
  • the current flowing in the circuit is sensed by a high-impedance operational amplifier 42 and recorded by a computer controlled data acquisition system 44.
  • An important aspect of the invention is the ability to form a high-resistance electrical seal 46 between the surface of substrate 28 and a biological membrane 48 without micromanipulation by a skilled technician.
  • the sample such as a cell containing the membrane is placed in suspension in top chamber 36, and drawn to hole 30 through the use of differential pressure applied between bottom chamber 38 and top chamber 36. It has been found and demonstrated that once a cell reaches a properly chosen and engineered substrate, an electrical seal of tens of M ⁇ to greater than 1 G ⁇ is achievable. Given this high seal resistance level, it is then possible to isolate and measure typical physiological whole cell currents (>50 pA) that occur when the ion channels in the cell membrane are activated.
  • the high electrical resistance seal also allows for the ability to control the voltage of the cell, a very useful feature in analyzing ion channel activity.
  • an electrode To achieve voltage clamp of the membrane, an electrode must be placed in electrical contact with the inside of the cell. This requires electrically permeabilizing the part of the cell membrane 52 separating the two fluid chambers. This permeabilization has been effected in the present device in two ways: (1) voltage pulses ("zapping") generated by electrodes 34 and 40; and (2) flowing proper concentrations of antibiotics (Nystatin or Amphotericin B) in bottom chamber 38. There also are many other types of chemicals (e.g., gramicidin, ATP, valinomycin, etc.) that could be used to provide electrical access to the cell interior. II. Preferred Substrate/ Aperture Geometries
  • the apparatus may be used with any suitable cell, organelle, vesicle, or other membrane system.
  • exemplary mammalian cell lines of interest in ion channel expression systems include Chinese Hamster Ovary (CHO) cells and Human Embryo Kidney (HEK) cells. These cells have mean diameters in the range of 10-20 ⁇ m.
  • Optimum hole size in the substrate is governed by several considerations. Holes that are too large can allow cells to pass through the hole (as opposed to sealing) when differential pressure is applied. In addition, holes that are too large can impede formation of higher seal resistances. On the other hand, holes that are too small can produce a higher electrical access resistance to the interior of the cell once an electrical seal is formed.
  • a preferred implementation features hole diameters in the range of 1-3 ⁇ m, although a wider range of hole diameters (e.g., 1-10 ⁇ m) is feasible depending on cell type.
  • the preferred hole diameter is on the order of a few micrometers, it is preferable that the unperforated substrate be thin (e.g., ⁇ 25 ⁇ m), at least near the hole periphery. The reasons for this are several. Thick substrates introduce the problem of a very narrow pore relative to the substrate thickness, which in turn makes it more difficult to achieve fluid access to the membrane.
  • Fluid contact is necessary to provide an electrical pathway to measure ion channel currents, as well as to provide the cell with a normal physiological environment. Also, when attempting to gain electrical access to the interior of the cell, a long narrow chamiel derived from using a thicker substrate will produce a higher electrical access resistance than that provided by a thinner substrate. As mentioned previously, a higher access resistance degrades system time resolution and the ability to voltage clamp the cell. In addition, any technique to machine the hole in the substrate is more difficult, time consuming, and costly when starting with a thicker substrate. As such, substrate materials utilized in these embodiments preferably had a thickness of less than 25 ⁇ m in their entirety or at least near the periphery of the hole.
  • an important consideration of this invention is in the choice of the substrate used, the manner in which the substrate is processed to form the hole and the specific geometry utilized to make the concept workable in a high-throughput instrament.
  • the choice and manufacture of the substrate two specific embodiments of the device have been demonstrated in our laboratory.
  • Holes were photomachined using a pulsed YAG laser operating at 355 nm.
  • a single laser beam drills an isolated hole, one at a time.
  • This beam is then scanned, typically using a galvanometric mirror scanning system to raster scan the incident beam over the substrate creating an array of photo-machined holes.
  • Such systems often employ an F-Theta lens system, which focuses as well as redirects the scanned laser beam so that the beam remains perpendicular to the target.
  • the throughput of the scanning arrangement thus is governed by the time to drill one hole and the speed of the optical scanner. It also is possible to produce an array of holes by scanning the film or substrate (instead of the incident beam) and leaving the optical illumination system fixed. Again, the throughput of this type of system is determined by the speed of the scanning system and the time to drill a single hole.
  • Holes also were photomachined using an excimer laser operating at 248 nm.
  • a photo-mask is imaged onto the substrate, and the surface is ablated where the unmasked optical energy is allowed to pass through to the substrate.
  • the excimer imaging process can machine single or multiple holes in the substrate simultaneously depending on the mask configuration.
  • a table scanning system is then used to move the substrate to create a larger two-dimensional pattern of photo-machined holes.
  • the substrates were cleaned and subjected to a physical vapor deposition (PND) of a silicon oxide SiO 2 coating using an RF sputtering process.
  • PND physical vapor deposition
  • the process involved pumping the system down to ⁇ 4 x 10 "6 torr using a cryo-pump, and subsequently backfilling the chamber with 7 mtorr of Argon.
  • the high RF field generated between two electrode plates then interacts with the Argon to produce an ion bombardment of a SiO 2 target.
  • the dislodged SiO 2 then is deposited onto the thin plastic film that is placed on a rotating platter running at 20 rpm. All operations are run at room temperature. Coating thicknesses implemented were in the range of 500 to 1000 angstroms.
  • FIG. 3 depicts two separate examples of a cell 58 positioned over a hole 56 in a thin layer substrate 54.
  • the holes are larger on one side than the other; the diameter on the smaller side of the pore is in the range of 1-3 ⁇ m.
  • a SiO 2 coating 60 is applied to the cell-side surface to improve seal formation. Both geometries have proven to be viable in achieving good electrical resistance between the cell membrane and the substrate.
  • Figures 4 and 5 demonstrate typical whole-cell electrophysiological data acquired on CHO cells transfected with the voltage gated potassium channels Kv3.2.
  • the substrate material was Kapton
  • the hole was photomachined with an excimer laser ( ⁇ 3 ⁇ m diameter)
  • the resultant substrate was coated with a 500 angstrom SiO 2 coating.
  • the cell was positioned onto the hole in the substrate using differential pressure of approximately 5 inches of H 2 0. After contacting the membrane, a seal resistance of approximately 1.3 G ⁇ was measured.
  • Figure 4 contains two data graphs relating to measured electrical leak resistance between a transfected CHO cell and a SiO coated Kapton® polyimide film membrane pore.
  • the top graph represents the applied command voltage placed on the measurement electrode. As shown, the voltage sweeps from -100 mN to +60 mN (range of 160 mN) over approximately a 90-msec time course.
  • the bottom graph represents measured current after the electrical seal was formed. As shown, the current over the same time course increased approximately 120 pA. Since the resistance of the cell membrane itself without ion channel activation is on the order of 10 G ⁇ , the measured current in this example is primarily due to leak resistance.
  • the whole-cell configuration was implemented using the antibiotic amphotericin B to chemically permeabilize the part of the membrane covering the hole. This was accomplished by flowing amphotericin B at a concentration of 200 ⁇ g/ml to the underneath side of the hole. The mode of action of this compound is then to partition into cell membranes, where it interacts with cholesterol to form tiny channels permeable to monovalent ions. This provides a low-resistance electrical access to the interior of the cell and in turn allows for control of the transmembrane voltage over the remaining unpermeabilized cell membrane.
  • Figure 5 contains two data graphs relating to the physiological measurement of the Kv3.2 chamiel activity after the application of amphotericin B and under "whole cell" conditions.
  • the top graph represents the applied voltage sweep, which ranged from —100 mN to +60 mN (same sweep as that of Figure 4), providing a measure of the voltage activity of the channel. As shown, there is practically no current present until approximately 50 msec into the sweep (transmembrane voltage of -10 mN), at which time the potassium channels open and a positive current (out of the cell) is recorded.
  • the bottom graph represents measured current generated by channel activity, where the voltage clamp was stepped sequentially for 90 msec intervals from a resting potential of -70 mN to the different respective voltages labeled on the graph. As shown, for this particular channel, current is slightly activated at a membrane potential of -20 mN, and is greatly activated at more positive potentials.
  • the front side of the wafer then was patterned with photoresist to allow for the removal of a 1 mm square section of all three oxide layers through Reactive Ion Etching (RJJE).
  • the back side of the wafer then was patterned to allow for the removal of a coincident 4 ⁇ m diameter section of the oxides, again through a reactive ion etch.
  • an anisotropic wet etch was performed in EDP to produce a pyramidal shaped hole from the front side of the wafer (1mm square) to the oxide layers on the back side of the wafer. This resulted in a 1- ⁇ m thick, 300- ⁇ m square membrane of oxides with a 4- ⁇ m diameter hole in the center.
  • This process may be extended to produce wafer substrates exhibiting 1 or 2-dimensional patterns of hundreds to thousands of holes. Individual cells then were positioned onto the individual etched holes using differential pressure, as described previously.
  • This section describes systems for conducting electrophysiological measurements, serially and/or simultaneously, on a plurality of samples.
  • These systems may include (A) a multiaperture substrate, (B) a plenum fluidics system (C) a plenum vacuum regulation system, (D) a sample handling / fluidics system, (E) an electronics / measurement system, (F) an activation system, and/or (G) a controller system, among others.
  • Figure 6 shows an exemplary multiaperture system, adapted to conduct simultaneous measurements on a plurality (e.g., an n x m grid) of samples, in accordance with aspects of the invention.
  • This system includes a measurement platform 70 for supporting various components of the system. These components include a plurality of function stations, including an analysis station 72 and one or more input stations 74, renewal stations 76, and/or cleaning stations 78, among others. These components also include a sample handling fluidics head 80 having a plurality of dispense elements 82, an electronics head 84 having a plurality of electrodes 86.
  • the multiaperture system of Figure 6 may be controlled via any suitable method, such as an external microcomputer 96, CRT display 98, and software user interface.
  • the system further may incorporate an embedded microcontroller, interfaced to the external microcomputer, for controlling real-time functional aspects of the instrument, including motion control, fluidics control, and electrical data recording.
  • the controller further may be interfaced with a three-dimensional mechanical gantry system 99 capable of independently moving the fluidics head (80) and the electronics head (84).
  • the fluidics and electronics heads may, without loss of function, independently comprise single probes, n x 1 (1 -dimensional) probes, as shown here, or n x m (2-dimensional) probes.
  • the combination of the controller and gantry systems allows for the spatially selectable transfer of potential drug candidates to the various n x m "wells" of the multi-well measurement substrate using the fluidics head, the spatially selectable activation of caged compounds, and/or the spatially selectable electrical recording from samples using the electronics head.
  • the system components most generally, be configured for independent and/or coordinated movement, with the individual components (or portions thereof) moveable and/or fixed, as desired, consistent with an ability to bring components into registration or aligmnent as needed for particular functions.
  • the fluidics head and a sample holder may be brought into register by moving the fluidics head, the sample holder, or both, using any suitable registration device or mechanism.
  • the measurement platform generally comprises any mechanism such as a planar surface for supporting and/or maintaining the spatial arrangement between some or all of the components of the measurement system.
  • Figure 7 is a top side view of one implementation of the measurement platform for use in high-throughput electrophysiological measurements, in accordance with aspects of the invention.
  • This layout includes eight separate linearly disposed fixture positions 124-131.
  • the electrical sensing head (104) can access three positions (124-126), the multi-channel dispensing head (106) can access six positions (126- 131), and both heads can access one position (126). More generally, the system platform layout may include any suitable number of positions, for any suitable functions, disposed and accessed in any suitable manner.
  • Position 126 is an analysis station, referred to as the plenum, which in turn is used to support the individual measurement substrates containing samples. This position may be accessed by the multi-channel dispensing head, to dispense samples, screening compounds, and the like, and by the electrical sensing head, to make electrophysiological measurements.
  • the plenum system reservoir creates an air-tight seal by locking the measurement substrate into position atop the plenum using a vacuum-induced differential pressure between the measurement substrate carrier and an o-ring situated on the plenum. This air-tight seal allows fluid in the plenum reservoir to be maintained at slightly less than atmospheric pressure, thereby introducing a differential pressure across the membrane that forces fluid from the top chamber through the individual apertures into the common lower reservoir.
  • the resulting flow pulls individual suspended cells (or cell membranes) in multi-well compartments down onto the individual apertures in parallel, without direct human intervention, hi addition, once the cells contact the membrane surface, the continued use of differential pressure enhances the formation of high-resistance electrical seals between the substrate material and the cell membrane.
  • Positions 128 and 131 are input stations, from which potential biological screemng compounds may be obtained.
  • the footprint for these positions preferably is compatible with 96, 384, and/or 1536-well microplates, as these are common receptacles for potential drug candidates (agonists or antagonists) used by the pharmaceutical industry.
  • Position 130 is another input station, from which extracellular fluid may be obtained.
  • This fluid preferably comprises a physiological saline solution for transfer by the fluidics head to the top side of the measurement substrate at position 126.
  • the station may include a removable boat that holds the saline solution; alternatively, or in addition, the station may be automated by priming it for automatic fill and drain via a peristaltic pump and a vacuum-assisted waste bottle.
  • Position 129 is yet another input station, from which cells or other biological samples may be obtained.
  • This station also may include a removable boat that contains cells or other user-prepared biological material in suspension for transfer by the multi-channel fluidics head to the top side of the measurement substrate.
  • Cellular samples may be maintained as a slurry, for example, with cell densities on the order of about 10° cells/ml.
  • the volume of cell slurry required for an experiment depends on the number of wells used in the experiment and on the volume of fluid dispensed into each well; for 384 wells, with 3-4 ⁇ l dispenses, the volume of slurry required is less than about 1.5 ml.
  • Position 124 is a renewal station for replenishing the chloride coating of the electrodes.
  • This station may include a removable boat that contains a solution (commonly bleach) for depositing chloride on the sensing pins of the multi-channel electrical read head. More generally, the station may include any apparatus or material suitable for maintaining, replenishing, and/or rejuvenating the electrodes.
  • Positions 125 and 127 are cleaning or wash stations for the electrical head and the multi-channel fluidics head, respectively.
  • the electrical and fluidics heads should be cleaned whenever they come into contact with potentially biologically active test compounds, to reduce or prevent carryover that may affect future measurements.
  • the two cleaning stations each include a manifold of input ports that preferably matches the dimensionality of the associated electronics or fluidics head, or a portion thereof (here, both 12 channels).
  • the two stations employ a design whereby cleaning fluid is pumped using a peristaltic pump from a source bottle through individual access ports 134 to overflow into a respective catch basins 136.
  • the stations may use any suitable cleaning solution to clean both the sensing pins from the electrical head and the dispense elements of the multi-channel fluidics head, for example, water and a cleaning solvent such as 10% ethanol for the fluidics head and a saline solution for the electronics head.
  • a cleaning solvent such as 10% ethanol for the fluidics head and a saline solution for the electronics head.
  • the inside of the needles from the fluidics head may be washed by performing fast aspirate/dispense cycles in association with flowing fluid through the individual input ports 134. Compartmentalizing the individual wash ports reduces wash volume and the potential for well-to-well contamination. It also forces fluid around the outside of the individual dispense needles of the fluidics head.
  • the waste basins drains directly into a vacuum-assisted waste bottle.
  • the close proximity of the wash stations (125 and 127) to the analysis chamber (126) reduces overall assay time by reducing the distance the respective electronics head (104) and fluidics head (106) must travel in performing
  • the input fluids typically include two saline solutions, at least for general electrophysiological experiments.
  • the first saline solution (source 136) comprises a mixture of salts that mimics the internal cytoplasm of a living cell e.g., containing high potassium.
  • This solution (denoted "internal:” buffer) may be used on the bottom side of the plenum fixture 154, which is the side by which electrical access to the interior of the cell is achieved.
  • This solution is analogous to the fluid inside the pipette in classical electrophysiology, and may be pumped in and out of the plenum system by a peristaltic pump 140.
  • the second saline solution (source 142) comprises a mixture of salts that mimics the extracellular solution, e.g., containing low concentrations of potassium.
  • This solution (denoted "external” buffer) maybe used on the top side of the measurement substrate, and may be added by the multi-channel fluidics head to the separate wells of the measurement substrate by accessing at position 162 and dispensing into the top side of the multi-well carrier at position 154.
  • the constituents of both the internal and external saline solutions may vary greatly, as is common in classical electrophysiology.
  • the input fluids also typically include a perforation solution (source 144), which can be accessed by the plenum pump 140 through proper valve actuation. This causes the perforation solution to flow into contact with the bottom side of the membrane substrate and thus to the biological membrane. Through chemical permeation, this solution serves to provide a low-resistance electrical pathway to the interior of the cell membrane.
  • the perforation solution preferably comprises an "internal" (high potassium) saline solution, mixed with an appropriate concentration of a chemical that subsequently provides a low electrical resistance access to the cell. This chemical may include, among others, amphotericin B, nystatin, gramicidin D, paradaxin, ATP, and so forth.
  • the system may replace the initial plenum solution 136 with this new solution 144 using the plenum peristaltic pump 140.
  • the fluid in the lower chamber of the plenum may be exchanged without introducing significant pressure pulsation or static pressure changes that could disrupt the process of high-resistance seal formation between the biological membrane and the multi-well substrate.
  • the expelled plenum solution is pumped out to a separate waste container 166 using pump 140.
  • This example shows only two plenum input solutions 136, 144; however, in practice, it is possible to include as many input solutions as necessary or desired.
  • the ability to exchange multiple internal solutions, i.e., the solution that has access to the inside of the cell, is not available in classical electrophysiology using a standard pipette.
  • Figure 9 shows the location of input 136 and output 168 reservoirs, relative to an instrument housing.
  • the input fluids are located on the left side of the instrument, and the output (waste) fluids are located on the right side of the instrument layout.
  • the system as shown includes four fluid inputs and two fluid outputs, but more generally may include as few or as many of each as necessary or desired.
  • the multiaperture substrate generally comprises any mechanism having a plurality of holes or apertures about which a corresponding plurality of samples may be positioned and/or sealed for analysis.
  • the substrate preferably has one aperture per sample well, although in some configurations there may be two or more apertures per sample.
  • the substrate also preferably allows each sample to be independently exposed to reagents, candidates, and/or other materials, for example, via separate sample wells in fluid isolation from other sample wells, at least on one side of the substrate.
  • Figure 10 shows an exemplary multiaperture substrate, comprising a multi- well membrane carrier 350, a thin membrane substrate 352, and the receiving plenum fixture 354.
  • the carrier 350 comprises the top, well-containing portion of the multiaperture substrate.
  • the carrier may be formed of any suitable material, by any suitable process, for example, injection-molded polystyrene.
  • the membrane substrate 352 comprises the surface and associated apertures onto which samples are sealed for analysis.
  • This substrate also may be formed of any suitable material, by any suitable process.
  • the substrate is formed of a thin plastic film (such as a Kapton® polyimide film or a Mylar® polyester film) that has been photo-machined (or otherwise provided) with an array of single apertures that match the geometry of the carrier, i.e., one aperture per well.
  • the carrier and cleaned, machined membrane substrate may be joined using any suitable mechanism (e.g., by a non-toxic adhesive or ultrasonic bond), forming an electrically isolated fluid chamber 356 on top of each aperture in the membrane.
  • this bonding may be achieved by applying a layer of adhesive between the membrane and carrier, which then is cured through a combination of time, heat, andVor ultraviolet light.
  • the assembly of carrier and membrane then forms a single substrate assembly that is assembled and packaged, preferably in a hermetically sealed pouch, in a clean room. Clean-room techniques are advantageous to reduce or eliminate foreign debris that may otherwise be introduced into the individual wells and potentially plug the small aperture at the bottom of each well during initial fluid flow.
  • the exemplary system described here includes a rectangular grid of 48 x 8 apertures that forms a 384-well substrate.
  • the apertures have a 2.25-mm center-to- center spacing, and the well volume that is formed by the carrier and membrane holds approximately 15 ⁇ l.
  • This geometry is only one of many that could be implemented in building such a device.
  • the illustrated design could be extrapolated to form arl array of 48 x 32 apertures (1536) wells having a 2.25-mm spacing.
  • the choice of center-to-center well spacing ideally should conform to a standard microplate format, so that the multi-channel fluidics head readily can access both compound plates and the membrane carrier.
  • the industry standard microplates have 96, 384, and 1536 wells with 9, 4.5, and 2.25 mm center-to-center well spacings, respectively.
  • the multi-well assembly is lowered into the top access of the plenum 354, where it may be clamped via a vacuum port 358 and o- ring assembly 360 located on the top surface of the plenum.
  • the seal achieved between the o-ring and the outer rim of the membrane carrier isolates the internal chamber of the plenum. This, in turn, allows regulation and alteration of the internal plenum fluidics path at pressures slightly below atmosphere, as just described.
  • the use of a vacuum chuck arrangement is a convenient (fast and efficient) interface for loading membrane/carrier substrates into the plenum fixture.
  • the plenum system generally comprises any mechanism for adding, removing, and/or replacing fluids and associated materials from the bottom side of one or more sample wells, sequentially and/or simultaneously, while typically providing a means to control the differential pressure across the substrate.
  • the plenum system preferably is closed, so that a differential pressure can be introduced, controlled, and/or regulated between the top side of the measurement substrate, which is at atmospheric pressure, and the bottom side of the measurement substrate, which generally is held at a slight vacuum.
  • This differential pressure may be used, as described above, to position a cell, vesicle, and/or other sample that is in the fluid on the top side of the membrane onto the small pore(s) located in each respective well of the measurement substrate.
  • the plenum system also may be used to replace air that initially is in the system with fluids from one or more fluid inputs. This replacement is necessary to provide a continuous fluid path, which allows a complete electrical circuit to be formed between the solutions above and below the membrane.
  • air must be removed from the various fluid pathway lines, as well as from the small aperture in the measurement substrate. Removing the air from the substrate is a difficult proposition, because the microscopic geometry of the aperture typically is a long narrow chamiel.
  • the plenum system also may be used to replace one fluid in the system with another during the measurement process, after electrical seals have formed. To do this effectively, without unduly disrupting the seal, the plenum system should be able to reduce or minimize pressure perturbations, as well as to control the differential pressure during the exchange process.
  • FIG 11 is a schematic representation of an exemplary plenum fluidics system, in accordance with aspects of the invention.
  • This system generally comprises any mechanism for regulating fluid access to the bottom side of the measurement substrate.
  • the system includes a plurality of fluid pathways (solid lines 171), preferably constructed of flexible silicone tubing and pneumatic pinch valves.
  • This arrangement allows for a stable, biologically inert pathway, which, with proper maintenance, can be kept clean, since the fluid is confined to the silicone tubing and not exposed to other valve components.
  • the pumping action may be provided by any suitable mechanism, such as a dual, 4-roller peristaltic pump 174. This allows for the maximum pumping efficiency, while minimizing the "pulsing" of the fluid flow as the rotor turns over the tubing.
  • the system also includes two debubblers 176 and 178, positioned on opposite sides of the plenum (169). These debubblers have several functions. First, and foremost, they are a convenient way to remove macroscopic bubbles from the system. Specifically, as a bubble floats into the partially filled debubbler tube, the bubble will float to the top and be removed from the fluid path. Second, the debubblers also serve as convenient control points for vacuum control. Third, the debubblers also act as a capacitive reduction to kinetic perturbations in pressure introduced by the pump during fluid flow.
  • the system may be filled with fluid by an appropriately sequenced actuation of various valves, in combination with pump flow.
  • a "pulsing" procedure may be implemented. This procedure may involve (1) running the pump at a moderate speed, (2) initiating an increase in positive pressure in the plenum by closing off the output side of the plenum at valves 180 182 and 184, and (3) relieving the increase in positive pressure by opening valve 180 temporarily.
  • the resulting pressure pulse may clear bubbles out of the system, which fluid flow via the peristaltic pump alone typically is not sufficient to do.
  • This debubbling is performed prior to adding cells or other samples to the system, since the pressure perturbations induced during this "priming" procedure may be too great to maintain an electrical seal between cell and membrane.
  • the pulsing may be performed while maintaining a negative absolute differential pressure in the system, even during the pulses, ensuring flow from the top side to the bottom side, so that potentially recycled and "dirty” solution from the bottom side of the plate should not flow backwards to the topside, thereby plugging the hole.
  • the fluid in the system may be exchanged with other fluids, also by an appropriate use of various valves and pump flow.
  • the plenum system may be opened at an input point, to accept new fluid, and at an exit point, to expel current fluid.
  • a valve 186 may be opened, and a 3-way valve 188 may be switched from the closed-loop flow position to the open-to-waste position.
  • the plenum vacuum regulation system generally comprises any mechanism for controlling (e.g., maintaining, regulating, and/or monitoring) the differential pressure across the measurement substrate 192.
  • This differential pressure generally may assume any value consistent with its intended function(s), which may include facilitating sealing of samples across the aperture and/or disrupting or destroying the portion of the sample sealed across the aperture.
  • the differential pressure for proper high-resistance seal formation typically assumes values in a range between 0 to 10 inches of water of vacuum with respect to atmosphere, with a precision of about 0.05 inches of water. This vacuum range encompasses the range that typically is applied to the pipette during seal formation in classical electrophysiology.
  • the plenum vacuum regulation system may include, among others, one or more of each of the following components: (1) a vacuum (or pressure) sensor, for sensing pressure, (2) a vacuum (or pressure) regulator, for controlling vacuum, (3) a debubbler(s), for reducing or eliminating bubbles, (4) a pump, for applying pressure, (5) a line, for routing fluid between sources, sinks, the plenum, and/or other positions, and (6) an environmental sensor and/or controller, for sensing and/or controlling environmental conditions, such as temperature, pH, and the like.
  • the exemplary regulation system includes an electronically voltage-controlled vacuum regulator 194 for controlling the differential pressure in the plenum in the desired range.
  • a regulated vacuum output line 196 responds to a vacuum sensing line 198 to maintain a desired vacuum level, as set by an analog voltage control.
  • Both the regulated output line and the sense line are connected to a trap bottle 200, winch serves as a protection mechanism for the sensor, as well as a form of ballast to aid the dynamics of the control system.
  • the outputs of the regulator are fed to two debubblers 202 and 204 (as referenced in Figure 11) in the plenum system, and to a plenum waste bottle 208, to maintain proper vacuum control points throughout the plenum system.
  • Control of the vacuum regulation system is made difficult by the small desired control range, typically 0 to 10 inches of water vacuum, relative to atmosphere.
  • the pre-debubbler 202 control point is located approximately 3 inches above the plenum interface, thereby providing 3 inches of water positive pressure offset (when the system is primed and filled with fluid) between the debubbler control point and the plenum 206.
  • This provides a convenient control offset, such that the regulator works in a stable, linear range during normal operation at about 3 inches H 0 of vacuum. This, in turn, allows the regulator system to control the differential pressure in the plenum accurately all the way to zero differential pressure relative to atmosphere.
  • the regulation system also may include a gauge or sensor 208, such as an analog gauge, that measures, in real time, the pressure differential between atmospheric pressure and the plenum.
  • This gauge may be used for feedback to the vacuum regulator or as a quality control system monitor to indicate to the user that all systems are operational and functioning properly. For example, if the membrane substrate is not sealed properly to the plenum, thereby allowing air into the system, the gauge will provide a mechanism for determining that the system is not at the proper differential pressure and so can be used to warn the user of a potential problem.
  • the sample-handling / fluidics system generally comprises any mechanism for adding, removing, replacing, and/or transferring fluids including samples, reagents, and/or drug candidates to the top side of one or more sample wells, sequentially and/or simultaneously.
  • the sample handling fluidics system is configured to introduce materials independently into the respective wells of the measurement substrate, as desirable in an instrument designed for parallel simultaneous measurements. These materials may include, among others, (1) physiological saline buffer, (2) suspended cells, cell membranes, vesicles, or beads with adherent membranes, and/or (3) experimental chemical entities, for example, for the purpose of analyzing their effect on the electrophysiology of the biological membrane.
  • the measurement fluidics system may obtain fluid from a source reservoir or multiwell plate and then dispense the same fluid in a destination reservoir, e.g., the multi-well carrier, using one or more pipette channels.
  • cell positioning may be accomplished using any suitable method, for example, by applying differential pressure across the substrate to increase fluid flow through each aperture, as described earlier. The cells then are carried by the fluid flow to the single aperture in each well of the multi-well chamber, at which time an electrical seal can form.
  • the accuracy, precision, and volume specifications of the fluidics head may be selected as necessary or desired, depending on the types of samples under study, the intended throughput of the instrument, and the intended quality of the measurements.
  • the fluidics head is capable of accurate (-2%) and precise ( ⁇ 2% CN) fluid aspiration and dispense cycles, at volumes of about 3 to 4 ⁇ l.
  • the ability to dispense fluids with accuracy and precision is motivated by the desirability of adding known concentrations of given biologically active compounds to the sample compartments to facilitate repeatable, comparative biological assays, as well as to provide for well-to-well comparison of compound activity.
  • the ability to dispense low volumes of fluid is motivated or necessitated by the geometry of the membrane carrier, which in the preferred embodiment has a full- well capacity of about 15 ⁇ l, and by the functional requirements of the assay, which may involve making 3-4 additions per assay.
  • FIG 11 shows an exemplary fluidics head 212, in accordance with aspects of the invention.
  • This head includes twelve (12) dispensing elements 214 and an "extra" cherry-picking dispense element 216 off to the side.
  • the dispense elements comprise stainless steel needles, coated both inside and out with Teflon® tetrafluoroethylene polymer to reduce the effects of compounds adhering to the surface of the needle and causing a carry-over problem for subsequent runs.
  • Fluid transfer e.g., the process of loading and/or dispensing fluids
  • Fluid transfer preferably is accomplished using a piston/o-ring manifold assembly 218, driven by a micro-stepping motor and precision lead screw assembly, that deposits fluid in individual sample compartments 220.
  • This motor and other stepping motors in the system are disabled before making electrical measurements, to reduce noise.
  • the "extra" dispense element in this design covers cases in which it is necessary or desirable for the instrument to perform single channel head pipetting. For example, in the screening mode, not all individual wells of the membrane substrate will form high resistance electrical seals and provide physiologically relevant data. Moreover, individual cells or membranes may vary in their ion channel expression levels, so that not all of the biological samples will contain the ion channel of interest.
  • the compounds are added to the measurement substrate quickly using a multi-channel pipettor, without regard to which wells are physiologically viable, then it is likely that some of the test compounds will not reach a physiologically viable well.
  • the probability of such an event depends on the probabilities of the cell forming a high-resistance seal in each individual well, the cell and other components of the system allowing electrical access to the cell to clamp the voltage, the cell having the ion channel(s) of interest, and the amount of replication used in adding the test compounds, among other factors.
  • One approach that may increase the probability of obtaining a valid test sample is to pre-sample the wells, and then only to add test compounds to those wells that are known to be physiologically viable.
  • the drawback of this approach is that it requires extensive pre-testing and a lot of single channel pipetting, which may greatly increase the time necessary to sample the entire multi-well substrate.
  • test compounds from a multi-channel pipettor, without regard to which wells have adequate electrical seals and physiological currents.
  • the most expedient way to cover the test wells is to add the compounds systematically to "most" of the plate using the multichannel pipettor (in duplicate or triplicate perhaps) and then to go back after the experiment with a single channel pipettor to "re-test" (after the fact) those compounds that did not have a viable data point.
  • This type of retest strategy relies on using a single channel pipettor during the "retest” phase so as not to corrupt neighboring test wells or to waste reagents and to use the remaining "good” wells efficiently, while minimizing the amount of single-channel pipetting that must occur.
  • the use of the fluidics head maybe illustrated by an example.
  • all compounds from a 96-well drug plate were added in triplicate to 288 wells (3 x 96) of a 384 well membrane substrate. This operation could be performed quite quickly using a multi-channel pipettor.
  • physiological currents were measured in 50% of the wells, i.e., that there were 192 "good" wells with high resistance electrical seals and measurable physiological currents. If this success rate were distributed randomly, we would then expect 1/8 (12) of the compounds to have 3 good measurements, 3/8 (36) of the wells to have 2 good measurement, 3/8 (36) of the wells to have 1 good measurement, and 1/8 (12) of the wells to have 0 good measurements.
  • the problem with this approach is that it requires two separate fluidics heads: one multi-channel and the other single-channel. This necessitates using either two sets of four-axis motion controllers (X, Y, Z, dispense), one for each head, or one four- axis motion controller, with separate, individually docked heads.
  • the fluidics head described here may overcome both of these complexities, by attaching a separate dispense element to the assembly, offset in X, Y, and Z (height). In multi-channel operation 222, this extra dispense element clears the other fluidics positions (due to the X Y Z offset).
  • the multi-channel head does not interfere with anything on the platform, and the single tip can access any position of the measurement substrate or compound plates (due to the clearance provided by the Z offset).
  • the advantage of this approach is its simplicity in that it avoids having a multiplicity of motion control and/or docking systems.
  • This approach and the preferred design are extendable to other one-dimensional or two-dimensional formats, including lines and grids.
  • the electronics / measurement system generally comprises any mechanism for applying and/or measuring electrical potentials and/or currents from one or more samples, in one or more sample wells, sequentially and/or simultaneously.
  • FIGS 14 and 15 show an exemplary electronics / measurement system, in accordance with aspects of the invention. Electrophysiological measurements may be performed on cells, using this system, by forming an electrical circuit across each individual aperture in the substrate. This may be accomplished using suitable electrodes, positioned on opposite sides of the membrane, for example, a sense electrode positioned above the membrane, and a ground electrode positioned below. For convenience, particularly in multichannel embodiments, electrodes may be mounted and manipulated collectively using an electronics head.
  • the electronics head may include a plurality of individual measurement probes, each capable of functioning as a sensing (or ground) electrode for an individual well of the measurement substrate, sequentially and/or simultaneously.
  • the electronics head may be capable of two- or three- dimensional motion, enabling it to move between the various wells of the measurement substrate, as well as to a wash station, where the individual sensing electrodes can be washed between experimental runs.
  • Each sensing electrode may be tied to its own high-impedance amplifier arrangement, consistent with that necessary for such measurements, preferably located in the housing of the electronics head.
  • the analog output signals for each of the respective output amplifiers may be digitized by appropriate analog-to-digital (A/D) converters and transferred to an internal (onboard) computer and/or an external computer for further processing.
  • A/D analog-to-digital
  • the individual circuits may be completed by the addition of a suitable electrolyte (e.g., saline) solution in each individual well of the measurement substrate above the membrane and by the introduction of saline solution below the membrane via a plenum, as described above.
  • a suitable electrolyte e.g., saline
  • a common ground electrode may be located in the plenum fluid reservoir, thereby completing the measurement circuit.
  • FIG 14 shows a partial schematic of an exemplary electronics head 226, in accordance with aspects of the invention.
  • This exemplary electronics head is configured, consistent with the discussion above, to move a plurality of sensing electrodes 228 to the various wells 230 of the multi-well measurement substrate 232, thereby completing a separate electrical circuit 234 for each of the measurement wells.
  • the electronics head includes several measurement "pins" 228.
  • Each pin typically is a silver or silver-coated wire.
  • the pins have comprised silver-plated stainless steel to improve their rigidity. Any type of wire material that can be silver-plated could potentially suffice.
  • This wire is treated, typically with a hypochlorous acid, to give it a silver/silver chloride coating.
  • the current-carrying mechanism between the biological cell or membrane and the pin then is transferred via a saline solution containing chloride ions, which react with the silver/silver chloride composite of each pin.
  • the advantage of using the silver/silver chloride electrode is that it has an extremely low junction potential. Once on the pin, this current may be converted to a voltage via a high-gain, low-noise trans-impedance amplifier 236.
  • the voltage signal then is sent off to a multi-channel analog-to-digital AID converter 246, which digitizes the voltage and saves it as a digital value in computer memory.
  • Each electrode pin has its own channel; however, for the sake of simplicity, not all are shown in Figure 14.
  • each measurement circuit may be accomplished via a suitable electrode, such as a silver/silver chloride pellet 238 that is located in the bath solution 240 in the plenum.
  • the bath solution in ' this embodiment should contain chloride ions for the silver/silver chloride electrode to function properly.
  • the preferred functionality required of the electronics head is to make current measurements for each measurement well, as well as to maintain or alter the voltage across each individual well and therefore across the biological membrane.
  • this amplifier arrangement should be capable of clamping the voltage over physiological voltage ranges (at least about -100 to 100 mV), as well as be able to detect currents on the order of 10 " Amps with a temporal bandwidth of about 10 kHz.
  • These specifications are rather demanding, but may be attained using state-of-the-art operational amplifier circuits and printed circuit board layouts. In addition, depending on the number of measurements to be made in parallel, these specifications can place demanding requirements on the multi-channel AID converter.
  • FIG 15 shows an example of such a system, whereby two separate banks of electrode pins are utilized.
  • a digital control line 248 controls the voltage input to two banks (250 and 252) of sensing pins via the selectable input lines 251 and 253. These input lines are connected directly to the non-inverting input of a low-noise operational amplifier.
  • One control line 254 contains a voltage waveform going to the "active" sensing bank.
  • the other input control line 256 is maintained at a fixed holding level.
  • the respective outputs of the two amplifier banks then are multiplexed to a multichannel A/D converter 258 via a multi-channel analog multiplexer 260 and digital multiplexer control line 262.
  • This type of multiplexing scheme has many advantages for high-throughput electrophysiological measurements.
  • the ability to voltage clamp many wells simultaneously at the holding potential greatly increases throughput for assays requiring significant holding times.
  • many sodium channels require 30 to 60 seconds of hold time at a negative voltage (e.g., -90 mV) before they will respond to a voltage stimulus.
  • the ability to hold many samples simultaneously, and to multiplex the sensing electrodes between "output hold potentials" and “variable output/input sensing potentials,” essentially removes this "inactivation state" in many wells in parallel, thereby improving the overall throughput of the measurements.
  • the alternative would be sequential hold times and/or the necessity to move the electronics head between measurement locations.
  • the electronics system described in this section more generally may be implemented for any suitable number and combination of amplifier banks (holding and active) and individual pin-counts (i.e., 12, 24, 48 etc.).
  • the system may, for example, be used with a 1536-well measurement system and a 192-pin electronics head, among others, multiplexed to a 12, 16, or 48 channel A/D converter. This exemplary system would allow the voltage to be held on up to 192 wells, at the same time.
  • the activation system generally comprises any mechanism for rapidly activating (and/or deactivating) effector compounds in one or more sample wells, sequentially and/or simultaneously.
  • the system may use suitable light from a suitable light source to activate a photoactivatable compound, and/or a suitable voltage or change in voltage from a suitable voltage source to activate a voltage- activated compound, and so on.
  • the system preferably uses light to "uncage" a photoactivatable "caged compound” comprising a ligand, a candidate ligand modulator, and/or the like.
  • Figure 16 shows an exemplary photoactivation system, in accordance with aspects of the invention.
  • This system which is associated here with an electronics head 282, includes a light source module 290 for generating light and a light coupler 292 for directing that light to one or more sample wells in a measurement substrate.
  • the photoactivation system and the electronics / measurement system are adapted to work in concert to concurrently photoactivate compounds and record electronic signals such as voltages and/or currents from the same wells. This adaptation allows for the rapid and direct activation of effector compounds (e.g., through UN flash photolysis of a caged compound) and the simultaneous electrical recording of time- critical, ligand-activated ion channel or ion transporter events.
  • the light source module generally includes a light source 294 capable of generating light that in turn is capable of or adaptable to activate the photoactivatable compound.
  • Suitable light sources may include continuous and/or time- varying sources, such as arc lamps, flash lamps, lasers, photodiodes, light-emitting diodes (LEDs), and/or electroluminescent lamps, among others.
  • Preferred light sources for activating caged compounds include ultraviolet (UN) light sources, such as UN lasers and UV lamps.
  • the light source module may control or modify one or more properties of the light outputted by the light source, such as its wavelength, intensity, polarization, and/or the like (e.g., using spectral filters, intensity filters, polarizers, and/or the like, respectively).
  • the light source module also may control the timing of the delivery of the light onto the sample, including the start time and the duration of the illumination. This control may be achieved by pulsing the light source and/or by adding intervening gating optics, such as filters, shutters, acousto-optic modulators, and so on.
  • the light coupler generally comprises any mechanism for directing light from the light source onto one or more of the samples.
  • Suitable light couplers may include optical fibers 298, free space optics, and/or evanescent wave coupling through the base of the substrate.
  • Suitable light couplers further may include conventional optical elements such as mirrors, beam splitters, diffusers, collimators, telescopic optics, and/or the like, which may be used as appropriate in place of, or in addition to, the components previously described.
  • the light may be directed onto the same well or sets of wells in contact with the electrical system, or a subset thereof, to facilitate coordinated activation and electrical measurement.
  • the photoactivation system may be controlled by a central processing unit (CPU).
  • the CPU preferably is capable of controlling the optical pulse width and intensity of the source, so that the timing, duration, and light energy of the ultraviolet exposure can be controlled automatically.
  • This section describes exemplary experimental protocols for using an electrophysiological measurement apparatus, in accordance with aspects of the invention.
  • the protocols begin with flushing and rinsing the instrument with the appropriate saline solutions, after which the user loads a multi-well carrier into the plenum fixture, which then is sealed by the application of high vacuum. This creates an air-tight vacuum controlled reservoir system on the bottom side of the membrane.
  • the fluidics head then aspirates enough volume from the external (low-potassium) buffer reservoir to dispense approximately 3.5 ⁇ l into every well of the 384 (8 x 48) multi-well carrier. Once this is accomplished, the plenum fluidics system begins pumping high potassium (internal) saline solution into the plenum fluidics system.
  • the plenum replaces the air in the plenum system reservoir with the high potassium solution. This procedure is carried out while maintaining a slight vacuum ( ⁇ 7-9 inches of H 2 0) with respect to atmosphere in the plenum system, ensuring that any fluid flow across the measurement substrate is from the topside to the bottom side.
  • the fluidics head optionally may be set to dispense fluid into a user-selectable subset of the sample wells, such as one-fourth or one-half of the wells, among others.
  • the partially filled plate then may be used for experiments, such as assay development, in which fewer (e.g., 96 or 192) measurements are necessary.
  • the remaining, pristine portion of the plate then may be used for a subsequent assay, if at all.
  • the electronics head will sample each well of the multi-well substrate electrically to test for electrical continuity through the from the top side, through the photo-machined hole, to the bottom side ground electrode on each well of the substrate.
  • This operation is pronounced of the "bath test" in classical electrophysiology. Under normal operation, and with typical saline solutions, the equivalent resistance of each photo-machined hole is on the order of 2 to 4 MOhms, although other holes sizes and effective resistances could yield acceptable results.
  • the differential pressure across the measurement substrate is turned off, so as not to pull debris through the open hole during this phase of the experiment.
  • Figure 17 is a screendump of an exemplary "hole test" from 48 wells of a measurement sequence.
  • the hole test may be used to measure resistance by applying a small, square- wave test voltage to each pin of the electronics head, and measuring the resultant current from the respective trans-impedance amplifier.
  • the individual plots show the measured current and the resulting resistance of each photo-machined hole in MOhms.
  • the instrument uses these recordings to document the quality of the multi-well substrate and to verify that all systems are operational before proceeding with biological measurements.
  • the instrument also uses these recordings to verify that each well of the multi-well substrate has effectively "primed,” thereby yielding a measurable resistance.
  • An air bubble present in a microhole at this point would yield an "open" circuit," resulting in a very large resistance measurement (e.g., several GOhms), and as such can be used to "flag" a problem in system performance.
  • a statistical measure from the "hole test” measurements may be used to correct the subsequent voltage waveforms for voltage offsets present due to artifacts associated with liquid junction potentials (formed at the interface of the internal and external saline solutions) or day-to-day variations in the absolute silver/chloride electrode potentials.
  • the fluidics head proceeds to aspirate a sufficient volume from a (previously prepared) cell slurry reservoir to dispense approximately 3-4 ⁇ l of slurry into the top-side of every well of the multi- well carrier. This operation is performed while a slight differential vacuum is placed across the substrate, ensuring fluid flow (top to bottom) through each individual photo-machined hole in the substrate. This top to bottom flow ensures that during the sealing process only clean "external" buffer comes into contact with the microhole.
  • the system waits approximately 3-5 minutes, allowing differential pressure to pull a cell to each individual hole of the substrate and also allowing for high-resistance seal formation to take place.
  • the electronics head performs a "seal test” by again applying a square-wave voltage (typically 10 mV amplitude), and measuring the resultant current from each respective trans-impedance amplifier.
  • Figure 18 is a screendump from 48 wells of a measurement sequence. The average seal resistances have improved from approximately 3 MOhms during the "hole test” to approximately 150-200 MOhms during the "seal test”. This difference in resistance is due to an individual cell lodging itself into the microhole, thereby increasing the resistance from the top-side chamber to the bottom side reservoir.
  • the instrument typically exchanges fluids in the plenum reservoir beneath the substrate, replacing the high potassium internal solution with one containing a perforation solution. This exchange process is performed using the plenum peristaltic pump and at static differential vacuum, so as to maintain the previously achieved seal resistance between biological membrane and substrate.
  • Typical plenum fluid exchange times are on the order of 60 seconds, after which the fluid in the plenum is "cycled" for several minutes.
  • the perforation agent forms low-resistance electrical pathways through the accessible biological membrane at each micro-hole interface. Depending on the agent and the biological membrane of interest, this process can take anywhere from 5 minutes to 30 minutes to stabilize. Typical perforation times are on the order of 10 minutes.
  • Figure 19 consists of an electrical read made after achieving voltage clamp, whereby a voltage waveform was applied that depolarized the cells from a resting potential of -90 mV to 0 mV for approximately 100 msec.
  • the biological membranes under study were CHO (Chinese Hamster Ovary) cells stably transfected with a sodium channel. As shown, upon depolarization, a small inward current measuring on the order of a few nA (10 ⁇ 9 Amp) is present with the characteristic time signature of Na channel recordings.
  • the time scale of Figure 19 is only 15 milliseconds wide, reflecting the fact that the Na channels, once activated, quickly inactivate within about 3-5 milliseconds.
  • One measurement sequence comprises taking a pre-compound recording from each well, followed by the addition of an experimental compound by the fluidics head. Because of potential failures in making recordings in each well, the system must build in a level of redundancy to ensure that every experimental compound is tested. Depending on the cell type and assay, typical success rates are on the order of 50- 80%. Failures may reflect a number of factors, including imperfect substrate priming, cell debris reaching the hole before a valid cell, and cells not having the particular ion channel current of interest, hi the preferred embodiment, to ensure a valid measurement, a particular experimental compound is added to multiple wells of the multi-well substrate. This provides some system redundancy at the expense of compound throughput, i.e., the number of different compounds that can be analyzed per day.
  • the fluidics heads adds each well of a 96 well compound plate (or one quadrant of a 384 well compound plate) to each of the 384 (8 x 48) wells of the measurement substrate 4 times. After each successive and distinct compound addition, the fluidics head returns to the wash reservoir, where washing solution is supplied to each fluidics head needle. The fluidics head initiates a multiple aspirate/dispense cycle coincident with wash fluid being pumped to the needle in a process that ensures that both the inside and outside of the fluidics head needles are cleaned effectively before grabbing the next compound set.
  • the electronics head revisits the substrate, initiating the same recording sequence to measure the effect of each compound on a post-compound recording. Measurements in this manner allow the direct comparison of the same cell before and after the addition of an experimental compound. This makes the measurement "differential” in nature, allowing for good assay performance even in the presence of widely varying individual ion channel current levels, as each well can serve as its own control. In addition, differential measurements offer the advantage, in the case of inhibition-type assays, to discriminate between cells that have particular ion channel current expression and those that do not. Cells without expression on the pre-compound recording thus can be excluded from post-analysis.
  • the experimental compounds may be added first, followed by a single electrical measurement read.
  • Some protocols rely on two fluid additions, e.g., in the case of ligand-gated assays in which a known agonist is added to initiate a response, followed by an electronic read, compound read, and post read.
  • a second top side fluid addition can be used to add a known control, either for normalization of prior signals or to ensure that each well has the has the necessary ion channel currents of interest.
  • the apparatus may be used using any suitable set of steps, as determined by the cell, channel, test compound, assay format, and so on.
  • the remainder of this section describes without limitation a few exemplary experimental protocols, or portions thereof, to supplement those presented above:
  • D. Assay 4. Add caged compound, stimulate and pre-read simultaneously, add test compound, stimulate and post-read simultaneously, compare pre-read and post- read. This protocol may be used with caged (or activatable) compounds to initiate a simultaneous and rapid stimulation / read of a fast ligand-gated channel.
  • E. Assay 5. Add caged compound, add test compound, stimulate and post-read simultaneously. This protocol does not use a pre-read, but again assumes that most cells have a current of known or average value (e.g., due to known channel expression).
  • F. Assay 6. Pre-read, add test compound, post-read, add known compound (agonist or antagonist), re-read. The last read may be used for calibration of the data.
  • This section describes exemplary aspects of software control and analysis, including (1) experiment set-up and control, (2) data analysis and reduction, and (3) leak reduction.
  • the system control software is presented as a graphical user interface, allowing the user to program various aspects of system control and data analysis. Examples of system control aspects include experiment scheduling, voltage waveform definition and timing, and compound addition scheduling and timing.
  • Figure 20 shows the GUI interface for overall experiment timing, as well as data file naming and directory designation.
  • Figure 21 shows the dialog box used to establish the number of wells to be tested (expressed as a percentage of the total), as well as the voltage waveform and timing to be associated with the "seal test" measurement.
  • Figure 22 shows the set-up and timing required for the addition of the perforation agent.
  • Figure 23 shows the dialog box associated with the definition of the voltage waveform, pre-holding voltages, and timing, as well as data sampling rates.
  • Figure 24 shows a dialog box used to define the compound addition sequence, timing, incubation time, and offset voltage corrections.
  • the system software also provides the means for analyzing data. Because the measurement process (prime, seal, measurable physiological current) does not have a 100%o probability of success in each well, the system has built-in a level of redundancy, whereby a single experimental compound is added to multiple (typically 4) measurement wells.
  • the software analysis includes in part the ability to deconvolve the various redundant measurement wells that are associated with a given experimental compound, analyze and scale the various time signatures associated with pre and post compound temporal recordings, and highlight areas of interest on the measurement plate according to various defined metrics.
  • Figure 25 depicts a compound plate view in which the software has been set up to compile the 4 individual compound measurements showing not only how many measurements (of the 4 possible) per compound were successful, but also to highlight according to % inhibition (post-read to pre-read comparison) the effects of the various compounds on the measurements.
  • This latter feature is useful in tracking assay integrity as every plate can include positive and negative controls (wells which initiate a response and well that should not) so as to verify the robustness of the particular assay.
  • Figure 25 shows that column 11 represents wells that show a greater than 50% inhibition of signal, whereas column 12 represents wells that show less than 50% inhibition. This type of view can give the user a visual and efficient quantitative assessment of assay quality.
  • Figure 26 is the result from one such drill down on a "negative control well", i.e., a well which should initiate no post-read inhibition. Shown on the plot are the pre and post- compound time signals for the 4 associated measurement wells corresponding to this non-active compound.
  • Another interesting and necessary feature of the data analysis software is the ability to define data "metrics" which compress the temporal signals according to user-defined mathematical expressions into simple numbers for post-analysis processing. Such metric definitions are essential in analyzing data from any high- throughput instrument, as it is difficult for an end-user to inspect hundreds of time traces generated every 30 minutes.
  • Figure 27 represents a metric definition window where the user has the ability to define various simple statistical measures, such as minimum, maximum, mean, etc., over a user-defined temporal region(s).
  • the metric is defined as the maximum of the individual time curves between time points 20.3 and 30, as referenced to the mean of the same time curve between time points 95 and 105. This resultant difference is saved as an absolute value.
  • the user then has the ability to take this simple process number (or metric) and export it to a file that easily can be accessed by various spreadsheet software packages for high-throughput plate-based analysis.
  • This type of metric definition and processing is particularly advantageous for the assays described here, due to the measurement throughput of the apparatus and the inability for a user to look at all the raw time trace information gathered per run
  • Another feature that is useful in the data acquisition software is the ability to change the data sampling rates during a voltage waveform, as well enabling user- definable "regions of interest" for data sampling. Due to the complex nature of ion channel gating, many assays require substantial and lengthy voltage setup protocols. However, in many of these cases, the useful and interesting physiological data is confined to a small interval or fraction of the entire protocol. Having the ability to down-select data acquisition to regions of interest greatly reduces the data handling and storage requirements of the system. Key examples of such protocols are those involving "use-dependent" pharmacological protocols, whereby the action of the drug increases the more times the channel is stimulated. During such protocols, it is not uncommon to want to stimulate the cell many times (10-50) over several minutes.
  • the pharmacological data of interest may only be a small fraction of the total post-compound waveform protocol, e.g., the first pulse and the last pulse of the stimulation train.
  • the user could specify a very short and defined region in which the data is actually digitized and subsequently saved to reduce the demands of down-stream data handling. This also can be accomplished in part by changing data sampling rates (or "gear shifting"), whereby regions of greater interest are sampled more finely (e.g., at about 1 kHz) than regions of lesser interest.
  • the leak current depends on the applied voltage waveform and the quality of the high-resistance seal. As an example, the leak current component would be approximately 1 nA for a 100 mV signal applied to a 100 MOhm seal.
  • Figure 28 demonstrates two electrophysiological traces, with and without leak correction. Both signals were obtained using a command voltage having a depolarization step to +50 mV at time point 20 msec using the delayed rectifying potassium channel Kvl.5, after the application of the time-dependent blocking compound, tedisamil. As shown, depolarization step causes a time-decaying physiological current over the depolarization pulse.
  • the command voltage waveform also contains a "pre-pulse,” comprising a small step voltage from -80 to -70 mV.
  • the pre-pulse may be conducted over any suitable voltage range, typically in the physiological (-100 to +60 mV) physiological range, in which there is little or no physiological current.) Relying on the fact that there is no physiological current triggered at these negative voltages, the measured current resulting from this pre-pulse can be used to isolate and subsequently estimate the leak current. This estimated value can then be used to "subtract" off the effects of the leak current during the entire voltage waveform, thereby yielding a true estimate of the baseline physiological current. Using this technique, we have been able to greatly increase the probability of success in making high-throughput electrophysiological recordings, by effectively lowering the acceptable high- resistance threshold from GOhms to tens of MOhms.
  • the invention provides systems, including apparatus and methods, for monitoring the influence of effector agents and their modulators on membrane electrical activity.
  • the effector agents may include activating/stimulatory agents and/or deactivating/inhibitory agents, among others, and modulators thereof.
  • the system may be used to study any suitable electrophysiological process or event, particularly those involving ligand-gated ion channels and/or transporters.
  • the system may be used with single samples, for example, using pipette-based or planar- substrate-based measurement devices.
  • the invention may be used with multiple samples, sequentially and/or simultaneously, thereby enabling the study of fast ligand-gated electrophysiological events in a high-throughput manner.
  • Suitable membrane components may include ion channels and ion transporters, among others, particularly ligand-gated channels and transporters.
  • Ion channels are membrane proteins that allow ions to flow across biological membranes, including the plasma membrane and organelle membranes. Ion channels are believed to create water-filled pores through which ions and some small hydrophilic molecules can pass by diffusion (i.e., the associated ion flow is passive, meaning that it occurs down a electrochemical gradient without requiring the input of energy.)
  • Ligand-gated channels open or close in response to the binding, reaction, and/or other association of signaling molecules, termed "ligands.” These channels may be gated by the binding of extracellular or intracellular ligands. In either case, the ligand is different than the substance that is transported when the channel opens. IV.A.1. Externally Gated Ion Channels
  • External ligands gate a variety of ion channels, including (1) ATP gated- channels, (2) glutamate-activated cationic channels, and (3) cys-loop superfamily channels.
  • the ATP-gated channel superfamily includes the ATP2x and ATP2z receptors, among others.
  • the glutamate-activated cationic receptor superfamily includes the ⁇ MDA, AMP A, and Kainate receptors, among others.
  • the cys- loop receptor superfamily includes the nicotinic acetylcholine receptor, GABAA and GABAc receptors, glycine receptors, 5-HT 3 receptors, and anionic glutamate receptors, among others. These particular channels are controlled by the ligands that appear in the names of the channels.
  • Neurotransmitters that is, chemical substances that transmit nerve impulses across a synapse, typically to another nerve cell or a muscle cell.
  • exemplary neurotransmitters include acetylcholine (Ach), amino acids (e.g., glutamic acid (Glu), glycine (Gly), and gamma aminobutyric acid (GABA)), catecholamines (e.g., noradrenaline and dopamine), miscellaneous monoamines (e.g., serotonin and histamine), and peptides (e.g., vasopressin (ADH), oxytocin, Gonadotropin-releasing hormone (GnRH), angiotensin ⁇ , cholecystokinin (CCK), substance P, and enkephalins such as Met-enkephalin and Leu-enkephalin), among others.
  • Ach acetylcholine
  • amino acids e.g., glutamic acid (Glu), g
  • GPCRs G-protein coupled receptors
  • chloride channels chloride channels
  • calcium-gated potassium channels among others.
  • GPCRs G-protein coupled receptors
  • cAMP cyclic AMP
  • cGMP cyclic GMP
  • Ca 2+ calcium-gated potassium channels
  • Ion transporters are membrane proteins that use energy such as that derived from ATP to force ions or small molecules though the membrane up their electrochemical gradients.
  • the fransporters may be (1) direct active transporters, binding ATP directly and using the energy of its hydrolysis to drive active transport, or (2) indirect active transporters, using ATP indirectly by using the downhill flow of a different type of ion to drive active transport, where the gradient of the different type of ion is created by a direct active transporter, allowing another transporter to create a gradient of a different type of ion, and then using.
  • Indirect transporters may be further subdivided into symporters and antiporters depending on whether the driving ion and the pumped ion (or other molecule) pass through the membrane in the same or opposite directions, respectively.
  • Exemplary direct active transporters include the Na + /K + ATPase and the H+ ATPase.
  • Exemplary indirect active transporters include (1) symporters such as the Na+/glucose transporter, the various amino acid/Na+ transporters, and the Na+/iodide transporter, and (2) antiporters such as the Na7K + ATPase.
  • Activatable compounds generally comprise any compounds, such as channel and/or transporter ligands, and modulators thereof, whose spatial and/or temporal release may be rapidly modulated by a suitable trigger, such as a change in light and/or voltage, among others.
  • Photoactivatable compounds which are triggered by light, are preferred for many applications.
  • Photoactivatable compounds are chemicals that are chemically altered such that the active nature of the compound is suppressed ("caged") until photoactivated, usually by a short pulse of ultra-violet (UV) light of wavelength in the range of 240 and 400 nm.
  • UV ultra-violet
  • the photolysis of such compounds is very fast and thereby can rapidly (in some cases in microseconds) release the active species of the compound.
  • Suitable methods for producing these compounds and exemplary embodiments thereof are described in the following publication, which is incorporated herein by reference in its entirety for all purposes: Richard P. Haugland, HANDBOOK OF FLUORESCENT PROBES AND RESEARCH CHEMICALS (6 th ed. 1996).
  • Photoactivatable compounds may be produced by derivatizing a ligand or modulator or other compound of interest with one or more photolabile protecting or caging groups. These caging groups, which collectively form a caging moiety, are selected and/or designed to interfere maximally with the binding, activity, and/or other function(s) of the derivatized compound. These groups may be detached rapidly (e.g., in microseconds to milliseconds) by appropriate illumination (e.g., flash photolysis at ⁇ 360 nm).
  • the groups may be incorporated into biologically active molecules using any suitable mechanism, for example, by linkage to a hetero-atom (e.g., O, S, or N) as an ether, thioether, ester (including phosphate or thiophosphate esters), amine, or similar functional group.
  • a hetero-atom e.g., O, S, or N
  • Exemplary caging groups may include (1) ⁇ -carboxy-2-nitrobenzyl (CNB) groups, (2) l-(2-nitrophenyl)ethyl (NPE) groups, (3) 4,5-dimethoxy-2-nitrobenzyl (DMNB) groups, (4) l-(4,5-dimethoxy-2- nitrophenyl)ethyl (DMNPE) groups, and (5) 5-carboxymethoxy-2-nitrobenzyl (CMNB) groups, among others.
  • CNB ⁇ -carboxy-2-nitrobenzyl
  • NPE l-(2-nitrophenyl)ethyl
  • DMNB 4,5-dimethoxy-2-nitrobenzyl
  • CMNB 5-carboxymethoxy-2-nitrobenzyl
  • Suitable photoactivatable compounds may include appropriately caged ligands, caged modulators, and the like, depending on the assay.
  • Exemplary caged ligands include caged neurotransmitters and caged second messengers.
  • Commericially available caged neurotransmitters include caged carbamylcholine, caged ⁇ - aminobutyric acid (GABA), caged N-methyl-D-aspartic acid, and caged L-glutamic acid, all of which are biologically inactive before photolysis (Molecular Probes, Eugene, Oregon, USA).
  • caged second messengers include caged cAMP, caged inositol 1,4,5-triphosphate, caged cADP-ribose, and caged Ca 2+ , at least several of which are membrane permeant (Molecular Probes).
  • Exemplary caged modulators include caged ligand chelators, which can bind up ligand already present so that it no longer can bind to channels.
  • Commercially available caged ligand chelators include caged Ca 2+ chelators (Molecular Probes).
  • the invention provides among others electrophysiological assays involving the use of activatable compounds, particularly for the study of ligand-gated membrane components such as ligand-gated channels and transporters.
  • Activatable compounds may be especially useful in high-throughput applications, because they can be used to "introduce” compounds into solution, near an appropriate receptor, without requiring that the compound be pipetted into the solution at the time of the electrical measurement. This capability may be especially useful in systems such as the specific embodiment described above, in which rapid introduction or perfusion, on the time scale of typical channel or transporter kinetics, is difficult.
  • the assays may have any suitable design. Typically, caged versions of a ligand or modulator will be introduced into a system, and then activated at a suitable time using a suitable trigger, such as application of light. The electrical activity of the sample may be measured before, during, and/or after activation, so that the kinetic effects of the uncaged compound on the phenomenon of interest can be studied.
  • the caged compound may be a caged ligand, with the assay monitoring the effects of the ligand on a channel or transporter, typically in the presence of a candidate modulator.
  • the caged compound may be a caged ligand chelator or caged ligand degrader, with the assay monitoring the effects of removing the ligand from a system potentially habituated to the ligand, for example, by binding it up or destroying it.
  • the caged compound may be a caged modulator, with the assay monitoring the effects of the modulator on a system already exposed to the ligand.

Abstract

Systèmes (dispositif et procédés) permettant d'exécuter des mesures électrophysiologiques sur des échantillons de membranes, dont des cellules vivantes et des fragments de cellule isolés (tels que des organites), et/ou sur des membranes artificielles (par exemple des vésicules). Le dispositif peut comporter un système de mesure de grande capacité et les composants qui s'y rapportent. Ce système de mesure peut comprendre, entre autres choses, (1) une tête fluidique assurant le transfert d'échantillons et/ou d'autre composés vers un substrat de mesure perforé, (2) un système de chambre à pression régulée pour le positionnement d'échantillons sur le substrat et la réalisation ultérieure d'un joint électrique à haute résistance, (3) un système d'activation (sous forme par exemple d'un module d'émission d'ultraviolets à impulsion commandé par ordinateur) activant les composés bloqués, (4) une tête électronique pour l'application et/ou la mesure d'une tension et/ou d'une intensité, et/ou (5) un système d'analyse commandé par ordinateur pour la collecte et/ou l'analyse de données. Ces procédés permettent notamment d'effectuer des mesures élecrophysiologiques à fort rendement sur des transporteurs et/ou sur des canaux ioniques dépendant de la tension ou de ligands, séquentiellement ou simultanément.
PCT/US2002/028398 2001-09-05 2002-09-05 Systeme de mesure electrophysiologique de grande capacite WO2003021230A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP02780275A EP1434850A2 (fr) 2001-09-05 2002-09-05 Systeme de mesure electrophysiologique de grande capacite
AU2002343338A AU2002343338A1 (en) 2001-09-05 2002-09-05 High-throughput electrophysiological measurement system

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US31711201P 2001-09-05 2001-09-05
US60/317,112 2001-09-05
PCT/US2002/016122 WO2002095357A2 (fr) 2001-05-21 2002-05-21 Systeme d'activation chimique rapide pour mesures electrophysiologiques a fort debit
USPCT/US02/16122 2002-05-21
US38319602P 2002-05-22 2002-05-22
US60/383,196 2002-05-22

Publications (2)

Publication Number Publication Date
WO2003021230A2 true WO2003021230A2 (fr) 2003-03-13
WO2003021230A3 WO2003021230A3 (fr) 2003-10-30

Family

ID=27359127

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/028398 WO2003021230A2 (fr) 2001-09-05 2002-09-05 Systeme de mesure electrophysiologique de grande capacite

Country Status (2)

Country Link
EP (1) EP1434850A2 (fr)
WO (1) WO2003021230A2 (fr)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004039489A2 (fr) * 2002-11-01 2004-05-13 Cellectricon Ab Produits programmes informatiques et systemes destines a modifier rapidement l'environnement de solution autour de capteurs
WO2005015210A1 (fr) * 2003-07-15 2005-02-17 Amphora Discovery Corporation Systeme de stimulation du champ electrique induit par le mouvement
WO2005016536A1 (fr) * 2003-08-04 2005-02-24 Caliper Life Sciences, Inc. Procedes et systemes permettant de traiter des dispositifs de petite echelle dans le but de les reutiliser
WO2005080971A1 (fr) * 2004-02-23 2005-09-01 Astrazeneca Ab Systeme et methode de mesures electrophysiologiques de fixation de tension planaire sur plusieurs cellules et leur utilisation dans l'identification d'agents modulant des canaux ioniques
US7514046B2 (en) 2000-10-31 2009-04-07 Caliper Life Sciences, Inc. Methods and systems for processing microscale devices for reuse
WO2013033225A2 (fr) 2011-09-02 2013-03-07 Molecular Devices, Llc Correction de décalage de tension dans un système de mesure électrophysiologique à haut rendement
CN108624496A (zh) * 2017-03-23 2018-10-09 洛阳华清天木生物科技有限公司 一种微生物诱变育种仪用样品传送及收集装置

Citations (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4071315A (en) * 1976-06-02 1978-01-31 Guy Chateau Analytical tape medium
US4952518A (en) * 1984-10-01 1990-08-28 Cetus Corporation Automated assay machine and assay tray
US5169600A (en) * 1987-07-15 1992-12-08 Fuji Photo Film Co., Ltd. Biochemical analysis apparatus for incubating and analyzing test sites on a long tape test film
US5262128A (en) * 1989-10-23 1993-11-16 The United States Of America As Represented By The Department Of Health And Human Services Array-type multiple cell injector
US5508200A (en) * 1992-10-19 1996-04-16 Tiffany; Thomas Method and apparatus for conducting multiple chemical assays
US5632957A (en) * 1993-11-01 1997-05-27 Nanogen Molecular biological diagnostic systems including electrodes
US6063260A (en) * 1994-10-28 2000-05-16 Neurosearch A/S Patch clamp apparatus and technique having high throughput and low fluid volume requirements
US6132582A (en) * 1998-09-14 2000-10-17 The Perkin-Elmer Corporation Sample handling system for a multi-channel capillary electrophoresis device
US20010005774A1 (en) * 1999-12-24 2001-06-28 Hirokazu Kato Automatic electrophysiological measuring apparatus / method
US20010005489A1 (en) * 1998-07-02 2001-06-28 Roach David J. Apparatus and method for filling and cleaning channels and inlet ports in microchips used for biological analysis
US6368851B1 (en) * 1998-05-27 2002-04-09 Micronas Gmbh Method and apparatus for measuring a state variable
US6377057B1 (en) * 1999-02-18 2002-04-23 The Board Of Trustees Of The Leland Stanford Junior University Classification of biological agents according to the spectral density signature of evoked changes in cellular electric potential
US6461860B2 (en) * 2001-01-25 2002-10-08 Axon Instruments, Inc. Alignment mechanism for two-electrode voltage-clamp perfusion chamber for electrophysiological testing of oocytes
US6470226B1 (en) * 1997-05-01 2002-10-22 Sophion Bioscience A/S Automatic electrode positioning apparatus
US6488829B1 (en) * 1999-08-05 2002-12-03 Essen Instruments Inc High-throughput electrophysiological measurement apparatus

Patent Citations (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4071315A (en) * 1976-06-02 1978-01-31 Guy Chateau Analytical tape medium
US4952518A (en) * 1984-10-01 1990-08-28 Cetus Corporation Automated assay machine and assay tray
US5169600A (en) * 1987-07-15 1992-12-08 Fuji Photo Film Co., Ltd. Biochemical analysis apparatus for incubating and analyzing test sites on a long tape test film
US5262128A (en) * 1989-10-23 1993-11-16 The United States Of America As Represented By The Department Of Health And Human Services Array-type multiple cell injector
US5508200A (en) * 1992-10-19 1996-04-16 Tiffany; Thomas Method and apparatus for conducting multiple chemical assays
US5632957A (en) * 1993-11-01 1997-05-27 Nanogen Molecular biological diagnostic systems including electrodes
US6063260A (en) * 1994-10-28 2000-05-16 Neurosearch A/S Patch clamp apparatus and technique having high throughput and low fluid volume requirements
US6470226B1 (en) * 1997-05-01 2002-10-22 Sophion Bioscience A/S Automatic electrode positioning apparatus
US6368851B1 (en) * 1998-05-27 2002-04-09 Micronas Gmbh Method and apparatus for measuring a state variable
US20010005489A1 (en) * 1998-07-02 2001-06-28 Roach David J. Apparatus and method for filling and cleaning channels and inlet ports in microchips used for biological analysis
US6132582A (en) * 1998-09-14 2000-10-17 The Perkin-Elmer Corporation Sample handling system for a multi-channel capillary electrophoresis device
US6377057B1 (en) * 1999-02-18 2002-04-23 The Board Of Trustees Of The Leland Stanford Junior University Classification of biological agents according to the spectral density signature of evoked changes in cellular electric potential
US6488829B1 (en) * 1999-08-05 2002-12-03 Essen Instruments Inc High-throughput electrophysiological measurement apparatus
US20010005774A1 (en) * 1999-12-24 2001-06-28 Hirokazu Kato Automatic electrophysiological measuring apparatus / method
US6461860B2 (en) * 2001-01-25 2002-10-08 Axon Instruments, Inc. Alignment mechanism for two-electrode voltage-clamp perfusion chamber for electrophysiological testing of oocytes

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7514046B2 (en) 2000-10-31 2009-04-07 Caliper Life Sciences, Inc. Methods and systems for processing microscale devices for reuse
WO2004039489A3 (fr) * 2002-11-01 2004-09-16 Cellectricon Ab Produits programmes informatiques et systemes destines a modifier rapidement l'environnement de solution autour de capteurs
WO2004039489A2 (fr) * 2002-11-01 2004-05-13 Cellectricon Ab Produits programmes informatiques et systemes destines a modifier rapidement l'environnement de solution autour de capteurs
WO2005015210A1 (fr) * 2003-07-15 2005-02-17 Amphora Discovery Corporation Systeme de stimulation du champ electrique induit par le mouvement
WO2005016536A1 (fr) * 2003-08-04 2005-02-24 Caliper Life Sciences, Inc. Procedes et systemes permettant de traiter des dispositifs de petite echelle dans le but de les reutiliser
AU2004265249B2 (en) * 2003-08-04 2007-07-05 Caliper Life Sciences, Inc. Methods and systems for processing microscale devices for reuse
WO2005080971A1 (fr) * 2004-02-23 2005-09-01 Astrazeneca Ab Systeme et methode de mesures electrophysiologiques de fixation de tension planaire sur plusieurs cellules et leur utilisation dans l'identification d'agents modulant des canaux ioniques
WO2013033225A2 (fr) 2011-09-02 2013-03-07 Molecular Devices, Llc Correction de décalage de tension dans un système de mesure électrophysiologique à haut rendement
EP2751552A2 (fr) * 2011-09-02 2014-07-09 Molecular Devices, LLC Correction de décalage de tension dans un système de mesure électrophysiologique à haut rendement
CN104335043A (zh) * 2011-09-02 2015-02-04 分子装置有限公司 高吞吐量的电生理学测量系统中的电压偏移校正
EP2751552A4 (fr) * 2011-09-02 2015-04-29 Molecular Devices Llc Correction de décalage de tension dans un système de mesure électrophysiologique à haut rendement
CN104335043B (zh) * 2011-09-02 2016-08-24 分子装置有限公司 高吞吐量的电生理学测量系统中的电压偏移校正
CN108624496A (zh) * 2017-03-23 2018-10-09 洛阳华清天木生物科技有限公司 一种微生物诱变育种仪用样品传送及收集装置

Also Published As

Publication number Publication date
EP1434850A2 (fr) 2004-07-07
WO2003021230A3 (fr) 2003-10-30

Similar Documents

Publication Publication Date Title
US7270730B2 (en) High-throughput electrophysiological measurement system
US6488829B1 (en) High-throughput electrophysiological measurement apparatus
JP4033768B2 (ja) 電気生理学的測定システム
WO2002095357A2 (fr) Systeme d'activation chimique rapide pour mesures electrophysiologiques a fort debit
US6932893B2 (en) System for electrophysiological measurements
JP5422125B2 (ja) センサー周辺の溶液環境を迅速に変化させるシステム及び方法
US20030104512A1 (en) Biosensors for single cell and multi cell analysis
US6984297B2 (en) Device for taking measurements of cells which are contained in a liquid environment
US8232074B2 (en) Nanoelectrodes and nanotips for recording transmembrane currents in a plurality of cells
JP4511189B2 (ja) センサーの周囲の溶液環境を迅速に変化させるシステム及び方法
US7201836B2 (en) Multiaperture sample positioning and analysis system
US7387715B2 (en) Sample positioning and analysis system
US20020164777A1 (en) Devices and methods for high throughput patch clamp assays
AU2001293676A1 (en) System for electrophysiological measurements
US20020064841A1 (en) Planar patch clamp electrodes
JP2004518109A (ja) 細胞上のパッチ−クランプ測定のための方法および装置
JP5948355B2 (ja) 電気生理学的分析のためのハンドヘルド装置
US20120040370A1 (en) Systems and methods for rapidly changing the solution environment around sensors
KR20040092371A (ko) 생체막의 전기적 분석
JP2008500516A (ja) インサイドアウト全細胞構成を用いた自動多重チャネルパッチクランプ記録法のための灌流システムおよび装置
EP1397677A1 (fr) Appareil et procede pour determiner et/ou surveiller les proprietes electrophysiologiques des canaux ioniques
EP1434850A2 (fr) Systeme de mesure electrophysiologique de grande capacite
WO2002065092A2 (fr) Dispositifs et procedes destines a des tests patch clamp a haut debit
JP3893381B2 (ja) 生体試料が発する電気信号を測定するための測定デバイスおよび測定方法
JP2010511412A (ja) センサー周辺の溶液環境を迅速に変化させるシステム及び方法

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VC VN YU ZA ZM

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2002780275

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2002780275

Country of ref document: EP

NENP Non-entry into the national phase in:

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2002780275

Country of ref document: EP